2023 Q4 Form 10-K Financial Statement

#000121390024033399 Filed on April 16, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $555.7K $1.029M
YoY Change 1958.68%
Operating Profit
YoY Change
Interest Expense $799.7K $2.284M
YoY Change
% of Operating Profit
Other Income/Expense, Net $9.600K $2.337M
YoY Change
Pretax Income $253.7K $1.308M
YoY Change -2716.2%
Income Tax
% Of Pretax Income
Net Earnings $253.7K $1.308M
YoY Change -2716.19%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.03 $0.22
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $367.3K $367.3K
YoY Change 1124.4% 1124.4%
Cash & Equivalents $367.3K
Short-Term Investments
Other Short-Term Assets $66.95K $66.95K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $434.3K $434.3K
YoY Change 1197.18% 1347.57%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $60.77M $60.77M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $60.77M $60.77M
YoY Change 25820.6% 25218.82%
TOTAL ASSETS
Total Short-Term Assets $434.3K $434.3K
Total Long-Term Assets $60.77M $60.77M
Total Assets $61.20M $61.20M
YoY Change 22743.62% 22566.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $395.5K $395.5K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $816.5K $816.5K
YoY Change 164.05% 163.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.021M $2.021M
YoY Change
Total Long-Term Liabilities $2.021M $2.021M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $816.5K $816.5K
Total Long-Term Liabilities $2.021M $2.021M
Total Liabilities $2.838M $2.838M
YoY Change 817.79% 815.45%
SHAREHOLDERS EQUITY
Retained Earnings -$636.4K
YoY Change 859.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$636.2K $58.36M
YoY Change
Total Liabilities & Shareholders Equity $61.20M $61.20M
YoY Change 22743.62% 22566.46%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $253.7K $1.308M
YoY Change -2716.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$159.7K -$650.8K
YoY Change 432.33% 1526.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$58.51M
YoY Change
Cash From Investing Activities $0.00 -$58.51M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.623M
YoY Change 11977.72%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $59.49M
YoY Change -100.0% 74263.58%
NET CHANGE
Cash From Operating Activities -159.7K -$650.8K
Cash From Investing Activities 0.000 -$58.51M
Cash From Financing Activities 0.000 $59.49M
Net Change In Cash -159.7K $333.8K
YoY Change -499.25% 734.61%
FREE CASH FLOW
Cash From Operating Activities -$159.7K -$650.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41664
CY2023 dei Entity Registrant Name
EntityRegistrantName
OAK WOODS ACQUISITION CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
101 Roswell Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Nepean
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
K2J 0H5
CY2023 dei Entity Address Country
EntityAddressCountry
CA
CY2023 dei City Area Code
CityAreaCode
(+1)
CY2023 dei Local Phone Number
LocalPhoneNumber
403-561-7750
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
58995000 usd
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 dei Auditor Name
AuditorName
Marcum Asia CPAs LLP
CY2023 dei Auditor Location
AuditorLocation
New York
CY2023 dei Auditor Firm
AuditorFirmId
5395
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
367321 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33478 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
66950 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
434271 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
33478 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
60765154 usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
234428 usd
CY2023Q4 us-gaap Assets
Assets
61199425 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58506250 usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
57500000 usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3431250 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
85340 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
295000 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
380340 usd
CY2022Q4 us-gaap Assets
Assets
267906 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
395506 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
14208 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
330969 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
816475 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
309208 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8900 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2012500 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2837875 usd
CY2022Q4 us-gaap Liabilities
Liabilities
309208 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
58997725 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24856 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-636353 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66302 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-636175 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-41302 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61199425 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
267906 usd
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1029342 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
66556 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1029342 usd
us-gaap Operating Expenses
OperatingExpenses
66556 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
25035 usd
us-gaap Interest Income Other
InterestIncomeOther
254 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
2258904 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-53500 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2337439 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
254 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1308097 usd
us-gaap Net Income Loss
NetIncomeLoss
-66302 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-66302 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-41302 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3368850 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
150780 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2146425 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
7418245 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1308097 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-636175 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1308097 usd
us-gaap Net Income Loss
NetIncomeLoss
-66302 usd
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
2258904 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-53500 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
66950 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
90000 usd
CY2023 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-330486 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-14208 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-650771 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52094 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
58506250 usd
CY2023 oaku Payment Of Underwriting Commission
PaymentOfUnderwritingCommission
1150000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
326355 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
234428 usd
CY2023 us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
-330969 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59490864 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
85572 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
333843 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
33478 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33478 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367321 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33478 usd
CY2023 oaku Deferred Underwriting Commission Fees Payable
DeferredUnderwritingCommissionFeesPayable
2012500 usd
CY2023 us-gaap Stock Issued1
StockIssued1
7418245 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57500000 usd
CY2023 oaku Transaction Cost
TransactionCost
3774095 usd
CY2023 oaku Underwriting Fee
UnderwritingFee
1150000 usd
CY2023 oaku Deferred Underwriting Fees
DeferredUnderwritingFees
2012500 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
611595 usd
CY2023Q4 us-gaap Cash
Cash
367321 usd
CY2023 oaku Fair Market Value Percentage
FairMarketValuePercentage
0.80 pure
CY2023Q4 us-gaap Tangible Capital
TangibleCapital
5000001 usd
CY2023Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage
1 pure
CY2023Q4 us-gaap Partners Capital Account Distribution Per Unit Of Limited Partner Interest
PartnersCapitalAccountDistributionPerUnitOfLimitedPartnerInterest
0.1
CY2023 oaku Maximum Allowed Dissolution Expenses
MaximumAllowedDissolutionExpenses
50000 usd
CY2023Q3 us-gaap Deposits
Deposits
330969 usd
CY2023 oaku Working Capital
WorkingCapital
382204 usd
CY2023 oaku Payment From The Sponsor
PaymentFromTheSponsor
25000 usd
CY2023 oaku Unsecured Promissory Note
UnsecuredPromissoryNote
500000 usd
CY2023 oaku Working Capital Loans
WorkingCapitalLoans
1151000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023 us-gaap Accretion Expense
AccretionExpense
7418245 usd
CY2023 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
57500000 usd
CY2023 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
1003390 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1293815 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3623315 usd
CY2023 us-gaap Stock Issued1
StockIssued1
7418245 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
58997725 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2023 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
1308097 usd
us-gaap Net Income Loss
NetIncomeLoss
-66302 usd
CY2023 us-gaap Stock Issued1
StockIssued1
7418245 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-6110148 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-66302 usd
CY2023 oaku Stock Issued During Period Value Sale Of Private Placement Units
StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
3431250 usd
CY2023 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
187500 shares
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
12.5
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1151000 usd
CY2023 oaku Additional Private Shares
AdditionalPrivateShares
115100 shares
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
500000 usd
CY2023Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
10000 usd
CY2023Q1 oaku Generated Gross Proceeds
GeneratedGrossProceeds
7500000 usd
CY2023 oaku Deferred Underwriting Fee
DeferredUnderwritingFee
0.035 pure
CY2023 oaku Cash Fee
CashFee
100000 usd
CY2023 oaku Share Issued Percentage
ShareIssuedPercentage
0.05 pure
CY2023Q4 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
300000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Shares Issued
SharesIssued
1437500 shares
CY2022Q4 us-gaap Shares Issued
SharesIssued
1437500 shares
CY2023 oaku Gross Proceeds Percentage
GrossProceedsPercentage
0.60 pure
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.2
CY2023Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
18
CY2023 oaku Issued Price Percentage
IssuedPricePercentage
1.80 pure
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18
CY2023 oaku Stock Issued During Period Share Sale Of Private Placement Unitsin Shares
StockIssuedDuringPeriodShareSaleOfPrivatePlacementUnitsinShares
343125 shares
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
60765154 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8900 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
oaku Payment Of Underwriting Commission
PaymentOfUnderwritingCommission
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments For Proceeds From Deposit On Loan
PaymentsForProceedsFromDepositOnLoan
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
oaku Deferred Underwriting Commission Fees Payable
DeferredUnderwritingCommissionFeesPayable
usd
us-gaap Stock Issued1
StockIssued1
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001945422

Files In Submission

Name View Source Status
0001213900-24-033399-index-headers.html Edgar Link pending
0001213900-24-033399-index.html Edgar Link pending
0001213900-24-033399.txt Edgar Link pending
0001213900-24-033399-xbrl.zip Edgar Link pending
ea0202346-10k_oakwoods.htm Edgar Link pending
ea020234601ex10-4_oakwoods.htm Edgar Link pending
ea020234601ex21-1_oakwoods.htm Edgar Link pending
ea020234601ex24-1_oakwoods.htm Edgar Link pending
ea020234601ex31-1_oakwoods.htm Edgar Link pending
ea020234601ex32-1_oakwoods.htm Edgar Link pending
ea020234601ex4-9_oakwoods.htm Edgar Link pending
ea020234601ex97-1_oakwoods.htm Edgar Link pending
ea020234601ex97-2_oakwoods.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fin_001.jpg Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
oaku-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
oaku-20231231_cal.xml Edgar Link unprocessable
oaku-20231231_def.xml Edgar Link unprocessable
oaku-20231231_lab.xml Edgar Link unprocessable
oaku-20231231_pre.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ea0202346-10k_oakwoods_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable